2020
DOI: 10.1111/hdi.12869
|View full text |Cite
|
Sign up to set email alerts
|

Patient‐reported outcomes from the investigational device exemption study of the Tablo hemodialysis system

Abstract: Introduction: We recently completed an Investigational Device Exemption (IDE) study in which 30 patients were enrolled (13 patients previously on home hemodialysis (HHD) and 17 patients new to HHD) and treated with the Tablo Hemodialysis System (Outset Medical, Inc., San Jose, CA) for 8 weeks in-center and 8 weeks in-home with an interim 2-4 week transition period for home training. Methods: In addition to assessments of urea kinetics, events related to safety, and operational issues (e.g., alarm resolution), … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 14 publications
(26 reference statements)
0
1
0
Order By: Relevance
“…The second aim of this study was to test whether activated carbon could increase the clearances of proteinbound uremic solutes in systems that use low dialysate flows. The desire to make hemodialysis available at home has motivated the development of several such systems (24)(25)(26). All of these systems provide adequate treatment, as assessed by the clearance of urea.…”
Section: Discussionmentioning
confidence: 99%
“…The second aim of this study was to test whether activated carbon could increase the clearances of proteinbound uremic solutes in systems that use low dialysate flows. The desire to make hemodialysis available at home has motivated the development of several such systems (24)(25)(26). All of these systems provide adequate treatment, as assessed by the clearance of urea.…”
Section: Discussionmentioning
confidence: 99%